NIH Hands Eye-Saving Peptides to Biotech Firm Exclusive Rights

2026-06501 — Government-Owned Inventions; Availability for Licensing

The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.

2026-05957 — Center for Scientific Review; Notice of Closed Meetings

The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.

2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings

The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.

2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)

The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!

2026-05673 — Center for Scientific Review; Notice of Closed Meetings

The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.

2026-05527 — Government-Owned Inventions; Availability for Licensing

The National Institutes of Health is offering a cool new gene-editing invention that can fix a rare genetic disease called ROSAH syndrome, which causes vision loss and other problems. Companies can license this technology to develop treatments that might restore vision and improve lives. Interested parties should act soon and be ready to sign a confidentiality agreement to get all the details.

Previous: 2026-06282 — Brightwood Capital SBIC IV, LP; Notice Seeking Exemption Under Section 312 of the Small Business Investment Act, Conflicts of Interest

Brightwood Capital SBIC IV, LP wants to lend money to The Smith and Oby Holding Company to help it grow. Because some related Brightwood funds already own a big chunk of Smith and Oby, this deal is a conflict of interest and needs special permission. People have 15 days from April 1, 2026, to share their thoughts before the SBA decides.

Next: 2026-06284 — Statement of Organization, Functions, and Delegations of Authority; Office of The National Coordinator for Health Information Technology

The Department of Health and Human Services is shaking things up by removing the Assistant Secretary for Technology Policy role and making the Office of the National Coordinator for Health Information Technology (ONC) a standalone office again. ONC will focus on leading health IT efforts without the extra tech roles like Chief AI or Data Officers. These changes take effect immediately and aim to streamline how health information tech supports Americans’ health.